Zhang YL, Li XB, Hou YX, Fang NZ, You JC, Zhou QH.
Acta Pharmacol Sin 2017; 38: advanced online publication, 2 Jan 2017.
The original version of this article was incorrectly given doi “10.1038/aps.2016.132”, which has been assigned to another article.
The correct doi is “10.1038/aps.2016.133”. This has been corrected in both PDF and HTML versions of the article.
The editors are sorry for the error.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found at 10.1038/aps.2016.133
Rights and permissions
About this article
Cite this article
Zhang, Yl., Li, Xb., Hou, Yx. et al. Erratum: The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer. Acta Pharmacol Sin 38, 443 (2017). https://doi.org/10.1038/aps.2017.3
Published:
Issue Date:
DOI: https://doi.org/10.1038/aps.2017.3
This article is cited by
-
LncRNA XIST Promoted OGD-Induced Neuronal Injury Through Modulating/miR-455-3p/TIPARP Axis
Neurochemical Research (2021)
